Altamira Medica AG
Switzerland Last updated 21 Oct 2026
- Devices
- 5
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
About
Altamira Therapeutics develops and supplies nanoparticles for delivery of therapeutic nucleic acids (siRNA, mRNA, circRNA or DNA) to extrahepatic targets
What Altamira Medica AG makes
Altamira Medica AG produces nanoparticle formulations for targeted delivery of therapeutic nucleic acids, including siRNA, mRNA, circRNA, and DNA, designed for extrahepatic (non-liver) tissue applications.
The company’s products are classified as Class IIa medical devices and are registered in the EU’s eudamed database. The manufacturer is based in Switzerland.
Frequently asked questions
How many devices does Altamira Medica AG have in the registry?
The registry currently lists 5 devices for Altamira Medica AG. Devices recorded under merged duplicate company entries are counted once.
Which registries list Altamira Medica AG's devices?
Among its 5 most recently registered devices, Altamira Medica AG has devices listed in EUDAMED (5 devices).
What risk classes do Altamira Medica AG's devices fall under?
Among its 5 most recently registered devices, the classes recorded for Altamira Medica AG's devices are Class IIa. Each device page shows its own class and authorisation.
What are the newest devices from Altamira Medica AG in the registry?
The most recently registered devices listed for Altamira Medica AG include BENTRIO.
Information
- Address
- 90, Peter Merian Strasse, Basel, Switzerland
- Website
- altamiratherapeutics.com/
- [email protected]
- Phone
- + 41 77 292 17 11
- PRRC contact
- Claire Noethel
- EUDAMED SRN
- CH-MF-000044549